EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Parenteral Iron Therapy: Examining Current Evidence for Use in Athletes

Nikita Fensham, Alannah Kelly Anne McKay, Marc Sim, Peter Peeling

International Journal of Sports Medicine · 01.06.2024 · 45 (07) · 496-503

DOI: 10.1055/a-2211-0813 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Sports Medicine, erschienen am 01.06.2024. Verfasst von Nikita Fensham und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Iron, Athletes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A high prevalence of iron deficiency exists in athlete populations. Various mechanisms, including increased losses through sweat, haemolysis, haematuria, and gastrointestinal micro-ischemia; inadequate dietary intake; and transient exercise-induced increases in the regulatory hormone, hepcidin, contribute to the increased prevalence in athletes. Indeed, hepcidin has been shown to peak around 3–6 hours post-exercise, limiting iron absorption from the gut. As the practitioner’s ability to control losses is limited, the key to treatment of iron deficiency in athletes is optimal timing of dietary and oral iron supplementation around these periods of reduced gut absorption. While timing and dosing schedule strategies might be sufficient to treat iron deficiency non-anaemia, the significant lag to impact iron status is relatively long. Therefore, in iron deficiency anaemia, the use of parenteral iron has the benefit of rapid repletion of iron stores and normalisation of haemoglobin status, while bypassing the action of hepcidin at the gut. Furthermore, newer intravenous formulations can be administered as a single total dose over 15–60 min and have a similar safety profile to oral treatment. This review discusses the existing evidence for parenteral iron use in athletes and the unique context for consideration when choosing the parenteral route in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Iron-DeficiencyIronAthletesHumansDietary SupplementsHepcidins

Substanzen

IronHepcidins

Autor:innen und Institutionen

  • Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
  • School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.
  • Medical School, The University of Western Australia, Perth, Australia.
  • School of Sport Science, Exercise and Health, The University of Western Australia, Crawley, Australia.
  • Western Australian Institute of Sport, Mt Claremont, Australia.

Zitieren

APA

Fensham, N., McKay, A. K. A., Sim, M., & Peeling, P. (2024). Parenteral Iron Therapy: Examining Current Evidence for Use in Athletes. International Journal of Sports Medicine, 45(07), 496-503. https://doi.org/10.1055/a-2211-0813

Vancouver

Fensham N, McKay AKA, Sim M, Peeling P. Parenteral Iron Therapy: Examining Current Evidence for Use in Athletes. International Journal of Sports Medicine. 2024;45(07):496-503. doi:10.1055/a-2211-0813

BibTeX
@article{Fensham2024,
  author = {Fensham, Nikita and McKay, Alannah Kelly Anne and Sim, Marc and Peeling, Peter},
  title = {Parenteral Iron Therapy: Examining Current Evidence for Use in Athletes},
  journal = {International Journal of Sports Medicine},
  year = {2024},
  volume = {45},
  number = {07},
  pages = {496--503},
  doi = {10.1055/a-2211-0813}
}
Kostenlos starten →